Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer March 31, 2021 Even in patients with stage 2 pancreatic cancer, surgery is typically worthwhile after chemotherapy, because it appears to extend patients' lives, a new study in the Journal of the American College of Surgeons concludes. The study was led by Dr. Amanda Arrington, a surgical oncologist at the University of Arizona College of Medicine – Tucson. HealthDay
UArizona Health Sciences Study Will Develop First Population-Based Dietary Assessment Mobile App March 30, 2021 Researchers are developing a mobile assessment tool to more accurately, and in near real-time, track and measure saturated fat and added sugar consumption. Read more Image
UArizona Leadership to Celebrate Ginny L. Clements and the Future of Breast Cancer Research March 30, 2021 Ginny L. Clements’ 65th anniversary as a breast cancer survivor and the future of breast cancer research and patient care will be discussed at the event. Read more Image
UArizona Health Sciences Primary Care Physician Scholarship Program Expands Eligibility to General Surgery Students March 30, 2021 The full-tuition program aims to improve Arizonans’ health and reduce medical student debt by addressing a dire need for qualified medical professionals. Read more Image
Community Leaders Humberto and Czarina Lopez Establish Two Endowed Chairs at UArizona March 30, 2021 The $3.5 million gift creates endowed chairs at Sarver Heart Center and the Eller College of Management. Read more Image
Confronting Vaccine Hesitancy with Facts and Empathy March 30, 2021 Experts from the College of Medicine – Tucson are working to counteract fears surrounding the COVID-19 vaccine. Read more Image
Research Where Parenting and Science Connect March 30, 2021 As a mother and a scientist, Veilia Leybas Nuño, PhD, was eager to study a family-focused intervention for children with ADHD. Read more Image
AZ HEROES “First of Its Kind” Study To Look at Vaccine Effectiveness March 30, 2021 Data from ongoing University of Arizona Health Sciences research have confirmed the findings from Phase III clinical trials conducted by Pfizer and Moderna for COVID-19 vaccine approval. The findings, published by the CDC, are the first in the U.S. to measure vaccine effectiveness against both symptomatic and asymptomatic COVID-19 specifically among first responders, health care and frontline workers. KOLD-TV (Tucson, AZ)
Medical Expert: Rescinding Mask Mandates Leaves Arizona Vulnerable March 30, 2021 Dr. Shad Marvasti, associate professor with the University of Arizona College of Medicine in Phoenix discusses the current state of COVID-19 in Arizona. KJZZ-FM (NPR) Phoenix, AZ